XML 64 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
Selected Quarterly Financial Data (unaudited) (Tables)
12 Months Ended
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Selected Quarterly Financial Information

The following table contains selected quarterly financial information for 2017 and 2016. The Company believes that the following information reflects all normal recurring adjustments necessary for a fair statement of the information for the periods presented. The operating results for any quarter are not necessarily indicative of results for any future period.

 

 

 

Three Months Ended

 

 

 

March 31,

2017

 

 

June 30,

2017

 

 

September 30,

2017

 

 

December 31,

2017

 

Revenue

 

$

 

 

$

 

 

$

 

 

$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

2,942

 

 

 

3,161

 

 

 

3,825

 

 

 

4,311

 

General and administrative

 

 

1,647

 

 

 

1,791

 

 

 

2,601

 

 

 

2,730

 

Total operating expenses

 

 

4,589

 

 

 

4,952

 

 

 

6,426

 

 

 

7,041

 

Loss from operations

 

 

(4,589

)

 

 

(4,952

)

 

 

(6,426

)

 

 

(7,041

)

Interest income

 

 

32

 

 

 

29

 

 

 

167

 

 

 

176

 

Net loss

 

 

(4,557

)

 

 

(4,923

)

 

 

(6,259

)

 

 

(6,865

)

Accretion of redeemable convertible preferred stock to redemption value

 

 

(20

)

 

 

(21

)

 

 

 

 

 

 

Net loss attributable to common stockholders

 

$

(4,577

)

 

$

(4,944

)

 

$

(6,259

)

 

$

(6,865

)

Net loss per share attributable to common stockholders—basic and diluted

 

$

(10.58

)

 

$

(10.98

)

 

$

(0.45

)

 

$

(0.47

)

Weighted average common shares outstanding—basic and diluted

 

 

432,728

 

 

 

450,495

 

 

 

13,939,950

 

 

 

14,720,734

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(4,557

)

 

$

(4,923

)

 

$

(6,259

)

 

$

(6,865

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on investments, net of tax of $0

 

 

 

 

 

 

 

 

(6

)

 

 

(27

)

Total other comprehensive loss

 

 

 

 

 

 

 

 

(6

)

 

 

(27

)

Total comprehensive loss

 

$

(4,557

)

 

$

(4,923

)

 

$

(6,265

)

 

$

(6,892

)

 

 

 

Three Months Ended

 

 

 

March 31,

2016

 

 

June 30,

2016

 

 

September 30,

2016

 

 

December 31,

2016

 

Revenue

 

$

 

 

$

 

 

$

 

 

$

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development

 

 

2,493

 

 

 

2,086

 

 

 

2,605

 

 

 

3,092

 

General and administrative

 

 

1,446

 

 

 

3,464

 

 

 

1,627

 

 

 

1,356

 

Total operating expenses

 

 

3,939

 

 

 

5,550

 

 

 

4,232

 

 

 

4,448

 

Loss from operations

 

 

(3,939

)

 

 

(5,550

)

 

 

(4,232

)

 

 

(4,448

)

Interest income

 

 

14

 

 

 

16

 

 

 

10

 

 

 

6

 

Net loss

 

 

(3,925

)

 

 

(5,534

)

 

 

(4,222

)

 

 

(4,442

)

Accretion of redeemable convertible preferred stock to redemption value

 

 

(18

)

 

 

(19

)

 

 

(19

)

 

 

(19

)

Net loss attributable to common stockholders

 

$

(3,943

)

 

$

(5,553

)

 

$

(4,241

)

 

$

(4,461

)

Net loss per share attributable to common stockholders—basic and diluted

 

$

(9.25

)

 

$

(12.95

)

 

$

(9.84

)

 

$

(10.31

)

Weighted average common shares outstanding—basic and diluted

 

 

426,487

 

 

 

428,870

 

 

 

430,929

 

 

 

432,413

 

Comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,925

)

 

$

(5,534

)

 

$

(4,222

)

 

$

(4,442

)

Other comprehensive loss:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrealized loss on investments, net of tax of $0

 

 

7

 

 

 

(5

)

 

 

(3

)

 

 

1

 

Total other comprehensive loss

 

 

7

 

 

 

(5

)

 

 

(3

)

 

 

1

 

Total comprehensive loss

 

$

(3,918

)

 

$

(5,539

)

 

$

(4,225

)

 

$

(4,441

)